Literature DB >> 27072672

Mounting Pressure in the Microenvironment: Fluids, Solids, and Cells in Pancreatic Ductal Adenocarcinoma.

Christopher C DuFort1, Kathleen E DelGiorno1, Sunil R Hingorani2.   

Abstract

The microenvironment influences the pathogenesis of solid tumors and plays an outsized role in some. Our understanding of the stromal response to cancers, particularly pancreatic ductal adenocarcinoma, has evolved from that of host defense to tumor offense. We know that most, although not all, of the factors and processes in the microenvironment support tumor epithelial cells. This reappraisal of the roles of stromal elements has also revealed potential vulnerabilities and therapeutic opportunities to exploit. The high concentration in the stroma of the glycosaminoglycan hyaluronan, together with the large gel-fluid phase and pressures it generates, were recently identified as primary sources of treatment resistance in pancreas cancer. Whereas the relatively minor role of free interstitial fluid in the fluid mechanics and perfusion of tumors has been long appreciated, the less mobile, gel-fluid phase has been largely ignored for historical and technical reasons. The inability of classic methods of fluid pressure measurement to capture the gel-fluid phase, together with a dependence on xenograft and allograft systems that inaccurately model tumor vascular biology, has led to an undue emphasis on the role of free fluid in impeding perfusion and drug delivery and an almost complete oversight of the predominant role of the gel-fluid phase. We propose that a hyaluronan-rich, relatively immobile gel-fluid phase induces vascular collapse and hypoperfusion as a primary mechanism of treatment resistance in pancreas cancers. Similar properties may be operant in other solid tumors as well, so revisiting and characterizing fluid mechanics with modern techniques in other autochthonous cancers may be warranted.
Copyright © 2016 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Drug Delivery; Gel Fluid; Hyaluronan; Interstitial Pressure; Pancreatic Ductal Adenocarcinoma

Mesh:

Year:  2016        PMID: 27072672      PMCID: PMC4957812          DOI: 10.1053/j.gastro.2016.03.040

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  93 in total

1.  A structural function of mucopolysaccharide in connective tissue.

Authors:  J H FESSLER
Journal:  Biochem J       Date:  1960-07       Impact factor: 3.857

Review 2.  Hyaluronan: from extracellular glue to pericellular cue.

Authors:  Bryan P Toole
Journal:  Nat Rev Cancer       Date:  2004-07       Impact factor: 60.716

Review 3.  General descriptions of passive transport of neutral solute and solvent through membranes.

Authors:  A G Ogston; C C Michel
Journal:  Prog Biophys Mol Biol       Date:  1978       Impact factor: 3.667

Review 4.  Interstitial-lymphatic mechanisms in the control of extracellular fluid volume.

Authors:  K Aukland; R K Reed
Journal:  Physiol Rev       Date:  1993-01       Impact factor: 37.312

Review 5.  Progress toward resolving the controversy of positive Vs. negative interstitial fluid pressure.

Authors:  R A Brace
Journal:  Circ Res       Date:  1981-08       Impact factor: 17.367

6.  Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma.

Authors:  Andrew J Aguirre; Nabeel Bardeesy; Manisha Sinha; Lyle Lopez; David A Tuveson; James Horner; Mark S Redston; Ronald A DePinho
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

7.  Genetically engineered models have advantages over xenografts for preclinical studies.

Authors:  Oren J Becher; Eric C Holland
Journal:  Cancer Res       Date:  2006-04-01       Impact factor: 12.701

8.  Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities.

Authors:  Bryan P Toole
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531

9.  Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy.

Authors:  Y Boucher; L T Baxter; R K Jain
Journal:  Cancer Res       Date:  1990-08-01       Impact factor: 12.701

10.  Disruption of Id1 reveals major differences in angiogenesis between transplanted and autochthonous tumors.

Authors:  Hashmat Sikder; David L Huso; Hong Zhang; Binghe Wang; Byungwoo Ryu; Sam T Hwang; Jonathan D Powell; Rhoda M Alani
Journal:  Cancer Cell       Date:  2003-10       Impact factor: 31.743

View more
  36 in total

Review 1.  Cancer Manipulation of Host Physiology: Lessons from Pancreatic Cancer.

Authors:  Constantinos P Zambirinis; George Miller
Journal:  Trends Mol Med       Date:  2017-04-08       Impact factor: 11.951

2.  Hyperthermia-enhanced targeted drug delivery using magnetic resonance-guided focussed ultrasound: a pre-clinical study in a genetic model of pancreatic cancer.

Authors:  Navid Farr; Yak-Nam Wang; Samantha D'Andrea; Frank Starr; Ari Partanen; Kayla M Gravelle; Jeannine S McCune; Linda J Risler; Stella G Whang; Amy Chang; Sunil R Hingorani; Donghoon Lee; Joo Ha Hwang
Journal:  Int J Hyperthermia       Date:  2017-07-17       Impact factor: 3.914

Review 3.  The plasticity of pancreatic cancer metabolism in tumor progression and therapeutic resistance.

Authors:  Douglas E Biancur; Alec C Kimmelman
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2018-04-24       Impact factor: 10.680

Review 4.  Targeting the tumour stroma to improve cancer therapy.

Authors:  Kenneth C Valkenburg; Amber E de Groot; Kenneth J Pienta
Journal:  Nat Rev Clin Oncol       Date:  2018-06       Impact factor: 66.675

Review 5.  Metabolic Interactions in the Tumor Microenvironment.

Authors:  Costas A Lyssiotis; Alec C Kimmelman
Journal:  Trends Cell Biol       Date:  2017-07-19       Impact factor: 20.808

6.  Fanning the Flames of Cancer Chemoresistance: Inflammation and Anticancer Therapy.

Authors:  Kenneth P Olive
Journal:  J Oncol Pract       Date:  2017-03       Impact factor: 3.840

Review 7.  Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright future.

Authors:  Eric S Christenson; Elizabeth Jaffee; Nilofer S Azad
Journal:  Lancet Oncol       Date:  2020-03       Impact factor: 41.316

8.  Tumor-Stroma IL1β-IRAK4 Feedforward Circuitry Drives Tumor Fibrosis, Chemoresistance, and Poor Prognosis in Pancreatic Cancer.

Authors:  Daoxiang Zhang; Lin Li; Hongmei Jiang; Qiong Li; Andrea Wang-Gillam; Jinsheng Yu; Richard Head; Jingxia Liu; Marianna B Ruzinova; Kian-Huat Lim
Journal:  Cancer Res       Date:  2018-01-23       Impact factor: 12.701

Review 9.  Targeting the Tumor Stroma: the Biology and Clinical Development of Pegylated Recombinant Human Hyaluronidase (PEGPH20).

Authors:  Kit Man Wong; Kathryn J Horton; Andrew L Coveler; Sunil R Hingorani; William P Harris
Journal:  Curr Oncol Rep       Date:  2017-07       Impact factor: 5.075

10.  Elastography Can Map the Local Inverse Relationship between Shear Modulus and Drug Delivery within the Pancreatic Ductal Adenocarcinoma Microenvironment.

Authors:  Hexuan Wang; Reem Mislati; Rifat Ahmed; Phuong Vincent; Solumtochukwu F Nwabunwanne; Jason R Gunn; Brian W Pogue; Marvin M Doyley
Journal:  Clin Cancer Res       Date:  2018-10-23       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.